Calder Biosciences announces clinical supply agreement with Biodextris to evaluate its lead RSV vaccine candidate as part of a Phase 1 clinical trial

vaccine - Trending on BuzzSumo 2023-06-06

Summary:

Calder Biosciences announces clinical supply agreement with Biodextris to evaluate its lead RSV vaccine candidate as part of a Phase 1 clinical trial prnewswire.com

Link:

https://www.prnewswire.com/news-releases/calder-biosciences-announces-clinical-supply-agreement-with-biodextris-to-evaluate-its-lead-rsv-vaccine-candidate-as-part-of-a-phase-1-clinical-trial-301843964.html

From feeds:

Tags:

all_vaccine

Authors:

Calder Biosciences

Date tagged:

06/06/2023, 12:53

Date published:

06/06/2023, 12:10